FAST vs TRDA · P/E 43, rev $7.55B vs P/E 12, rev $210.8M
Fastenal Company (FAST) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported FAST revenue for 2024-12-31 was $7.55B. Net income was $1.15B. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
FAST currently screens at market cap $49.48B and trailing P/E 43.1. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the FAST and TRDA stock pages for the full models.
Not investment advice.